Back to Journals » International Journal of Chronic Obstructive Pulmonary Disease » Volume 13

Effect of background long-acting beta2-agonist therapy on the efficacy and safety of a novel, nebulized glycopyrrolate in subjects with moderate-to-very-severe COPD

Total article views   Abstract views HTML views PDF downloads Totals
4,241 Dovepress* 3,354 553+ 1,155 3,907
PubMed Central* 0 334 137 334
Totals 3,354 887 1,292 4,241
*Since 19 September 2018
+Since July 2016

View citations on PubMed Central and Google Scholar